COEP logo

Coeptis Therapeutics (COEP) EBITDA

Annual EBITDA

-$20.16 M
+$16.20 M+44.55%

December 31, 2023

Summary

Performance

1-Year Change

+44.55%

3-Year Change

-132.1%

5-Year Change

-132.1%

15-Year Change

-132.1%

COEP EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.61%
COEP annual EBITDA is higher than 52.61% of companies in Healthcare sector

High & Low

All-time High

-$8.68 M

3-Year Low

-$36.35 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
COEP previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
COEP next annual earnings announcement has not yet been scheduled

OtherCOEPprofitabilitymetrics:

Annual Revenue

-
COEP annual revenue value is unknown

Annual Net Income

-$21.27 M
COEP annual net profit is -$21.27 million

Annual EBIT

-$21.16 M
COEP annual earnings before interest & taxes is -$21.16 million

Annual EPS

-$16.60
COEP annual earnings per share is -$16.60

Quarterly EBITDA

-$1.50 M
+$1.22 M+44.84%

September 1, 2024

Summary

Performance

3-Month Change

+44.84%

1-Year Change

+57.41%

3-Year Change

+84.19%

5-Year Change

+84.19%

COEP Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.1%
COEP quarterly EBITDA is higher than 66.1% of companies in Healthcare sector

High & Low

All-time High

-$1.50 M
COEP quarterly EBITDA is currently at an all-time high

3-Year Low

-$18.87 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
COEP previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
COEP next earnings announcement has not yet been scheduled

OtherCOEPprofitabilitymetrics:

Quarterly Revenue

-
COEP quarterly revenue value is unknown

Quarterly Net Income

-$1.83 M
COEP quarterly net profit is -$1.83 million

Quarterly EBIT

-$1.78 M
COEP quarterly earnings before interest & taxes is -$1.78 million

Quarterly EPS

-$1.00
COEP quarterly earnings per share is -$1.00

TTM EBITDA

-$10.29 M
+$4.55 M+30.66%

September 1, 2024

Summary

Performance

3-Month Change

+30.66%

1-Year Change

+48.95%

3-Year Change

+71.88%

5-Year Change

+71.88%

COEP TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.68%
COEP TTM EBITDA is higher than 60.68% of companies in Healthcare sector

High & Low

All-time High

-$1.91 M

3-Year Low

-$36.59 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
COEP previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
COEP next earnings announcement has not yet been scheduled

OtherCOEPprofitabilitymetrics:

TTM Revenue

-
COEP TTM revenue value is unknown

TTM Net Income

-$11.62 M
COEP TTM net profit is -$11.62 million

TTM EBIT

-$11.29 M
COEP TTM earnings before interest & taxes is -$11.29 million

TTM EPS

-$5.60
COEP TTM earnings per share is -$5.60

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$20.16 M
COEP annual EBITDA is -$20.16 million

Annual Net Income

-$21.27 M
COEP annual net profit is -$21.27 million

Annual Interest Expense

$107.70 K
COEP annual interest expense is $107.70 thousand

Annual Income Tax

$0.00
COEP annual income tax is $0.00

Annual D&A

$1.00 M
COEP annual depreciation & amortization is $1.00 million

COEP EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+44.5%+57.4%+49.0%
3 y3 years-132.1%+84.2%+71.9%
5 y5 years-132.1%+84.2%+71.9%

COEP EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-57.3%+44.5%at high+92.0%at high+71.9%
5 y5-year-132.1%+44.5%at high+92.0%-437.4%+71.9%
alltimeall time-132.1%+44.5%at high+92.0%-437.4%+71.9%

Coeptis Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.50 M(-44.8%)
-$10.29 M(-30.7%)
Jun 2024
-
-$2.72 M(+6.6%)
-$14.84 M(-1.3%)
Mar 2024
-
-$2.55 M(-27.6%)
-$15.03 M(-25.4%)
Dec 2023
-$20.16 M(-44.6%)
-$3.52 M(-41.8%)
-$20.16 M(+4.5%)
Sep 2023
-
-$6.05 M(+107.9%)
-$19.29 M(+3.8%)
Jun 2023
-
-$2.91 M(-62.1%)
-$18.58 M(-26.2%)
Mar 2023
-
-$7.68 M(+189.6%)
-$25.16 M(-30.8%)
Dec 2022
-$36.35 M
-$2.65 M(-50.4%)
-$36.35 M(+0.5%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$5.34 M(-43.7%)
-$36.18 M(-1.1%)
Jun 2022
-
-$9.49 M(-49.7%)
-$36.59 M(+22.9%)
Mar 2022
-
-$18.87 M(+663.3%)
-$29.77 M(+132.3%)
Dec 2021
-$12.81 M(+47.6%)
-
-
Dec 2021
-
-$2.47 M(-57.1%)
-$12.81 M(+23.9%)
Sep 2021
-
-$5.76 M(+115.6%)
-$10.34 M(+125.6%)
Jun 2021
-
-$2.67 M(+39.4%)
-$4.58 M(+139.4%)
Mar 2021
-
-$1.91 M
-$1.91 M
Dec 2020
-$8.68 M
-
-

FAQ

  • What is Coeptis Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Coeptis Therapeutics?
  • What is Coeptis Therapeutics annual EBITDA year-on-year change?
  • What is Coeptis Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Coeptis Therapeutics?
  • What is Coeptis Therapeutics quarterly EBITDA year-on-year change?
  • What is Coeptis Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Coeptis Therapeutics?
  • What is Coeptis Therapeutics TTM EBITDA year-on-year change?

What is Coeptis Therapeutics annual EBITDA?

The current annual EBITDA of COEP is -$20.16 M

What is the all time high annual EBITDA for Coeptis Therapeutics?

Coeptis Therapeutics all-time high annual EBITDA is -$8.68 M

What is Coeptis Therapeutics annual EBITDA year-on-year change?

Over the past year, COEP annual EBITDA has changed by +$16.20 M (+44.55%)

What is Coeptis Therapeutics quarterly EBITDA?

The current quarterly EBITDA of COEP is -$1.50 M

What is the all time high quarterly EBITDA for Coeptis Therapeutics?

Coeptis Therapeutics all-time high quarterly EBITDA is -$1.50 M

What is Coeptis Therapeutics quarterly EBITDA year-on-year change?

Over the past year, COEP quarterly EBITDA has changed by +$2.02 M (+57.41%)

What is Coeptis Therapeutics TTM EBITDA?

The current TTM EBITDA of COEP is -$10.29 M

What is the all time high TTM EBITDA for Coeptis Therapeutics?

Coeptis Therapeutics all-time high TTM EBITDA is -$1.91 M

What is Coeptis Therapeutics TTM EBITDA year-on-year change?

Over the past year, COEP TTM EBITDA has changed by +$9.87 M (+48.95%)